Vium Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vium's estimated annual revenue is currently $930k per year.(i)
  • Vium's estimated revenue per employee is $155,000

Employee Data

  • Vium has 6 Employees.(i)
  • Vium grew their employee count by 0% last year.

Vium's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Vium?

Vium is the first company to create a living informatics platform for preclinical in vivo drug research. The Vium Digital Vivarium™, incorporating Vium Smart Housing™, Vium Cloud infrastructure, and online Research Suite software, empowers scientists to optimize advances in bioengineered research models in ways previously not possible. Vium is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the “3 Rs,” the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical and computational drug discovery companies to academia and novel therapeutic labs. Investors include Lux Capital, Data Collective, Dolby Family Ventures, AME Cloud Ventures, and Founders Fund. For more information, please visit www.vium.com.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vium News

2022-04-06 - Mysterious Retro Biosciences Launches to "Increase Healthy ...

A year later he co-founded VIUM, raising $33 million to focus on automating in vivo research. The company was acquired by Recursion in 2020.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M60%N/A
#2
$0.1M60%$9.8M
#3
$0.9M6-40%N/A
#4
$0.9M60%N/A
#5
$0.4M6-50%N/A